|
October / November 2012
Features
The Show Must Go On
by Trenton Straube
The funds raised by Broadway Cares/Equity Fights AIDS support nearly 400 HIV and family service programs nationwide, as well as AIDS research and advocacy.
|
A Capital Affair
by Regan Hofmann
Science suggests that it’s possible for us to start to end AIDS. This July, the XIX International AIDS Conference gathered nearly 24,000 members of the global HIV/AIDS community to discuss whether we can make that possibility a reality.
|
From the Editor
Trench Warfare
by Regan Hofmann
The key message I hoped to hear at the XIX International AIDS Conference in Washington, DC, did in fact ring through loud and clear: Since we can begin to end AIDS, we must do so.
|
Feedback
The POZ Q+A
Full-Court Press
by Reed Vreeland
Scott A. Schoettes of Lambda Legal outlines the battle being waged in U.S. courts over HIV criminalization.
|
What You Need to Know
Jamar Rogers's Voice Will Go On
by Trenton Straube
We haven't heard the last of Jamar Rogers, the HIV-positive former meth addict who captured America's hearts and ears on The Voice.
|
We Hear You
Dr. No
by Reed Vreeland
A case of HIV discrimination by a medical practitioner made national headlines recently when a New Jersey man living with HIV sued a Catholic teaching hospital, Trinitas Regional Medical Center, for allegedly denying him access to treatment and visitors after he disclosed that he was gay and HIV positive.
|
POZ Survey Says
Taking Risks to Help Others
by Cristina González
All HIV-positive people alive today because of their meds owe a bit of gratitude to yesterday’s clinical trial volunteers.
|
What Matters to You
Finding an HIV Vaccine
by Cristina González
While HIV meds can keep positive people healthy and simultaneously lower their risk of spreading the virus, too few people have access to treatment for it alone to stop the epidemic.
|
Treatment News
Point of Reentry: Getting Prisoners HIV Care
by Laura Whitehorn
For the estimated 2 percent of prisoners in this country who are living with HIV/AIDS, release from prison brings challenges—finding housing and employment, reconnecting with family—that can make it difficult to maintain HIV treatment and care.
|
New Booster in Town: Cobicistat
by Laura Whitehorn
Cobicistat, a new pharmacokinetic (PK) enhancer from Gilead Sciences, is set to unseat Abbott’s Norvir (ritonavir) as the only approved HIV treatment booster.
|
Comfort Zone
Dear Diary
by Cristina González
Whether you’re grappling with a temporary frustration or an ongoing sense of anger or sadness, the act of writing about your negative feelings can help you turn them around.
|
POZ Heroes
Hip-Hop Soul
by Trenton Straube
When Kathleen Adams, a student at Fordham University in the Bronx, New York, surveyed the way women of color were portrayed in mainstream media, she didn’t like what she saw.
|
|
|
